Martini Maurizio, Teofili Luciana, Cenci Tonia, Giona Fiorina, Torti Lorenza, Rea Massimiliano, Foà Robin, Leone Giuseppe, Larocca Luigi Maria
Department of Pathology, Catholic University, Rome, Italy.
Haematologica. 2008 Jul;93(7):1068-71. doi: 10.3324/haematol.13210. Epub 2008 May 27.
HIF2A transcription factor plays a central role in the regulation of the hypoxia responding pathway in mammalian cells, by modulating erythropoiesis and angiogenesis. Molecular alterations of oxygen sensing pathway constituents are implicated in hereditary erythrocytosis. Here we show that 2 members of a family with idiopathic erythrocytosis exhibited a new heterozygous G to A mutation at base 1605 of the exon 12 of hypoxia-inducible factor-2A (HIF2A) gene. This mutation determines the replacement of methionine by isoleucine at the position 535, very close to the position 531, where the hydroxyl acceptor prolyne is located. In addition, we found that mRNA expression of erythropoietin receptor, vascular endothelial growth factor, transferrin receptor, adrenomedullin and N-myc downstream regulated gene 1, up-regulated by HIF2A or hypoxia, were significantly higher in patients carrying the mutation than in normal controls. These results suggest that the HIF2A(M535I) gene mutation could induce hereditary erythrocytosis at a young age.
缺氧诱导因子2A(HIF2A)转录因子通过调节红细胞生成和血管生成,在哺乳动物细胞缺氧反应途径的调控中发挥核心作用。氧感应途径成分的分子改变与遗传性红细胞增多症有关。在此,我们表明,一个患有特发性红细胞增多症的家族中的两名成员,在缺氧诱导因子2A(HIF2A)基因第12外显子的1605位碱基处出现了一个新的杂合G到A突变。该突变导致第535位的甲硫氨酸被异亮氨酸取代,该位置非常接近羟基受体脯氨酸所在的第531位。此外,我们发现,促红细胞生成素受体、血管内皮生长因子、转铁蛋白受体、肾上腺髓质素和N - myc下游调控基因1的mRNA表达,这些受HIF2A或缺氧上调的基因,在携带该突变的患者中显著高于正常对照。这些结果表明,HIF2A(M535I)基因突变可能在年轻时诱发遗传性红细胞增多症。